On October 13 local time, the U.S. Department of Health and Human Services (HHS) announced that HHS and Pfizer have reached an agreement to expand patient access to Paxlovid, which will begin rolling out to the commercial market in November 2023.

Pharmaceutical R&D Developer

The U.S. Department of Health and Human Services is a federal executive department dedicated to safeguarding the health of American citizens and delivering public services. Its mission is to protect and enhance the health of all Americans by providing effective health and human services, thereby advancing medicine, public health, and social development.
On October 13 local time, the U.S. Department of Health and Human Services (HHS) announced that HHS and Pfizer have reached an agreement to expand patient access to Paxlovid, which will begin rolling out to the commercial market in November 2023.